Osteopontin deficiency protects against obesity-induced hepatic steatosis and attenuates glucose production in mice
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1432-0428
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Osteopontin deficiency protects against obesity-induced hepatic steatosis and attenuates glucose production in mice ; volume:54 ; number:8 ; day:12 ; month:5 ; year:2011 ; pages:2132-2142 ; date:8.2011
Diabetologia ; 54, Heft 8 (12.5.2011), 2132-2142, 8.2011
- Urheber
-
Kiefer, F. W.
Neschen, S.
Pfau, B.
Legerer, B.
Neuhofer, A.
Kahle, M.
Hrabé de Angelis, M.
Schlederer, M.
Mair, M.
Kenner, L.
Plutzky, J.
Zeyda, M.
Stulnig, T. M.
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1007/s00125-011-2170-0
- URN
-
urn:nbn:de:101:1-2019111901535000195879
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:38 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Kiefer, F. W.
- Neschen, S.
- Pfau, B.
- Legerer, B.
- Neuhofer, A.
- Kahle, M.
- Hrabé de Angelis, M.
- Schlederer, M.
- Mair, M.
- Kenner, L.
- Plutzky, J.
- Zeyda, M.
- Stulnig, T. M.
- SpringerLink (Online service)
Ähnliche Objekte (12)
Mtfp1 ablation enhances mitochondrial respiration and protects against hepatic steatosis
Naringenin attenuates hepatitis B virus X protein-induced hepatic steatosis
PPARδ attenuates hepatic steatosis through autophagy-mediated fatty acid oxidation
Empagliflozin protects mice against diet-induced obesity, insulin resistance and hepatic steatosis
Targeting CYP4A attenuates hepatic steatosis in a novel multicellular organotypic liver model
Fluvastatin attenuates hepatic steatosis-induced fibrogenesis in rats through inhibiting paracrine effect of hepatocyte on hepatic stellate cells
Peripancreatic adipose tissue protects against high-fat-diet-induced hepatic steatosis and insulin resistance in mice
Stigmasterol attenuates hepatic steatosis in rats by strengthening the intestinal barrier and improving bile acid metabolism
Osteopontin attenuates aging-associated phenotypes of hematopoietic stem cells
Osteopontin attenuates aging-associated phenotypes of hematopoietic stem cells
Osteopontin attenuates aging‐associated phenotypes of hematopoietic stem cells
Betaine in ameliorating alcohol-induced hepatic steatosis
Mtfp1 ablation enhances mitochondrial respiration and protects against hepatic steatosis
Naringenin attenuates hepatitis B virus X protein-induced hepatic steatosis
PPARδ attenuates hepatic steatosis through autophagy-mediated fatty acid oxidation
Empagliflozin protects mice against diet-induced obesity, insulin resistance and hepatic steatosis
Targeting CYP4A attenuates hepatic steatosis in a novel multicellular organotypic liver model
Fluvastatin attenuates hepatic steatosis-induced fibrogenesis in rats through inhibiting paracrine effect of hepatocyte on hepatic stellate cells
Peripancreatic adipose tissue protects against high-fat-diet-induced hepatic steatosis and insulin resistance in mice
Stigmasterol attenuates hepatic steatosis in rats by strengthening the intestinal barrier and improving bile acid metabolism
Osteopontin attenuates aging-associated phenotypes of hematopoietic stem cells
Osteopontin attenuates aging-associated phenotypes of hematopoietic stem cells
Osteopontin attenuates aging‐associated phenotypes of hematopoietic stem cells
Betaine in ameliorating alcohol-induced hepatic steatosis
Mtfp1 ablation enhances mitochondrial respiration and protects against hepatic steatosis
Naringenin attenuates hepatitis B virus X protein-induced hepatic steatosis
PPARδ attenuates hepatic steatosis through autophagy-mediated fatty acid oxidation
Empagliflozin protects mice against diet-induced obesity, insulin resistance and hepatic steatosis
Targeting CYP4A attenuates hepatic steatosis in a novel multicellular organotypic liver model
Fluvastatin attenuates hepatic steatosis-induced fibrogenesis in rats through inhibiting paracrine effect of hepatocyte on hepatic stellate cells
Peripancreatic adipose tissue protects against high-fat-diet-induced hepatic steatosis and insulin resistance in mice
Stigmasterol attenuates hepatic steatosis in rats by strengthening the intestinal barrier and improving bile acid metabolism
Osteopontin attenuates aging-associated phenotypes of hematopoietic stem cells
Osteopontin attenuates aging-associated phenotypes of hematopoietic stem cells
Osteopontin attenuates aging‐associated phenotypes of hematopoietic stem cells